Date published: 2026-7-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

JAZF1 Double Nickase Plasmid (h): sc-404839-NIC

0.0(0)
Write a reviewAsk a question

Datasheets
  • Target species: human
  • 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
  • JAZF1 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
  • Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
  • One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
  • JAZF1 Double Nickase Plasmid (h) and JAZF1 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting JAZF1. One or both designs may be available
  • Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: JAZF1 Antibody (C-11): sc-376503
    Gene Editing Promo Banner

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    JAZF1 Double Nickase Plasmid (h)

    sc-404839-NIC
    20 µg
    $410.00

    JAZF1 Double Nickase Plasmid (h2)

    sc-404839-NIC-2
    20 µg
    $410.00

    JAZF1 (juxtaposed with another zinc finger protein 1) encodes a zinc finger transcriptional regulator implicated in controlling gene expression programs linked to cellular metabolism and differentiation. It has been associated with nuclear receptor signaling and transcriptional co-regulator networks that shape adipocyte and pancreatic islet biology. Genetic variation in JAZF1 is linked to susceptibility to type 2 diabetes and related metabolic traits, supporting its relevance for studies of glucose homeostasis and endocrine function. JAZF1 has also been investigated in the context of cancer biology and chromosomal rearrangements, making it useful for probing transcriptional dysregulation mechanisms in disease-relevant models.

    JAZF1 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the JAZF1 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within JAZF1. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt JAZF1 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.

    To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of JAZF1-disrupted clones.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.